Co-Amlessa tablets

Land: Armenië

Taal: Engels

Bron: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Download Productkenmerken (SPC)
01-10-2021

Werkstoffen:

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Beschikbaar vanaf:

KRKA d.d.

ATC-code:

C09BX01

INN (Algemene Internationale Benaming):

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Dosering:

8mg+ 10mg+ 2,5mg

farmaceutische vorm:

tablets

Eenheden in pakket:

(30/3x10/) in blister

Prescription-type:

Prescription

Autorisatie-status:

Registered

Autorisatie datum:

2021-07-21

Productkenmerken

                                PI_Text008889_1
– Updated:
Page 1 of 27
1.
NAME OF THE MEDICINAL PRODUCT
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Each tablet
contains 2 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 0.625 mg
indapamide.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Each tablet contains 8 mg perindopril tert-butylamine, 5 mg amlodipine
(as besilate) and 2.5 mg
indapamide.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
Each tablet
contains 8 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 2.5 mg
indapamide.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Co-Amlessa 2 mg/5 mg/0.625 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The score line is only to facilitate breaking for ease of
swallowing and not to divide into equal
doses.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets: White to almost white, round,
slightly biconvex tablets with
bevel edges.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The score line is only to facilitate breaking for ease of
swallowing and not to divide into equal
doses.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets with bevel
edges.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets scored on one
side with bevel edges. The score line is only to facilitate breaking
for ease of swallowing and not to
divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
CONFIDENTIAL
Co-A
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Russisch 01-10-2021

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten